Difference between revisions of "ArgC"
(→Expression and regulation) |
(→Expression and regulation) |
||
Line 92: | Line 92: | ||
* '''[[Sigma factor]]:''' [[SigA]] | * '''[[Sigma factor]]:''' [[SigA]] | ||
− | * '''Regulation:''' repressed by casamino acids [http://www.ncbi.nlm.nih.gov/pubmed/12107147 PubMed], repressed by arginine ([[ | + | * '''Regulation:''' repressed by casamino acids [http://www.ncbi.nlm.nih.gov/pubmed/12107147 PubMed], repressed by arginine ([[AhrC]]) |
− | * '''Regulatory mechanism:''' [[ | + | * '''Regulatory mechanism:''' [[AhrC]]: transcription repression |
* '''Additional information:''' | * '''Additional information:''' |
Revision as of 04:55, 28 May 2009
- Description: N-acetyl-g-glutamyl-phosphate reductase
Gene name | argC |
Synonyms | |
Essential | no |
Product | N-acetyl-g-glutamyl-phosphate reductase |
Function | biosynthesis of arginine |
MW, pI | 37 kDa, 5.167 |
Gene length, protein length | 1038 bp, 346 aa |
Immediate neighbours | yitZ, argJ |
Get the DNA and protein sequences (Barbe et al., 2009) | |
Genetic context This image was kindly provided by SubtiList
|
Contents
The gene
Basic information
- Coordinates:
Phenotypes of a mutant
Database entries
- DBTBS entry: [1]
- SubtiList entry: [2]
Additional information
The protein
Basic information/ Evolution
- Catalyzed reaction/ biological activity: N-acetyl-L-glutamate 5-semialdehyde + NADP+ + phosphate = N-acetyl-5-glutamyl phosphate + NADPH (according to Swiss-Prot)
- Protein family: Type 1 subfamily (according to Swiss-Prot)
- Paralogous protein(s):
Extended information on the protein
- Kinetic information:
- Domains:
- Modification:
- Cofactor(s):
- Effectors of protein activity:
- Interactions:
- Localization: cytoplasm (according to Swiss-Prot)
Database entries
- Structure:
- Swiss prot entry: P23715
- KEGG entry: BSU11190
- E.C. number: 1.2.1.38
Additional information
Expression and regulation
- Regulatory mechanism: AhrC: transcription repression
- Additional information:
Biological materials
- Mutant:
- Expression vector:
- lacZ fusion:
- GFP fusion:
- two-hybrid system:
- Antibody: